A third episode of transfusion-derived vCJD

Lancet

Volumn 368, Issue 9552, 2006, Pages 2037-2039

  Wilson, Kumanan ^a   Ricketts, Maura N ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; FOLLOW UP; HUMAN; INCUBATION TIME; INFECTION RISK; MORTALITY; PRIORITY JOURNAL; SAFETY;

EID: 33845186830     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69817-6     Document Type: Note

References (13)

1. Llewelyn C., Hewitt P., Knight R., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 (2004) 417-421
2. Peden A., Head M., Ritchie D., Bell J., and Ironside J. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364 (2004) 527-529
3. Wroe S., Pal S., Siddique D., et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion. Lancet 368 (2006) 2061-2067
4. Hunter N., Foster J., Chong A., et al. Transmission of prion diseases by blood transfusion. J Gen Virol 83 (2002) 2897-2905
5. Houston F., Foster J., Chong A., Hunter N., and Bostock C. Transmission of BSE by blood transfusion in sheep. Lancet 356 (2000) 999-1000
6. Bishop M., Hart P., Aitchison L., et al. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 5 (2006) 393-398
7. Hewitt P., Llewelyn C., Mackenzie J., and Will R. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 91 (2006) 221-230
8. National Blood Service, Scottish National Blood Transfusion Service, Welsh Blood Service, Northern Ireland Blood Transfusion Service, National CJD Surveillance Unit. Transfusion medicine epidemiology review (2006). http://www.cjd.ed.ac.uk/TMER/fate.htm (accessed Dec 3, 2006)
9. Ludlam C., and Turner M. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products. Br J Haematol 132 (2006) 13-24
10. Wilson K., and Ricketts M. The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt-Jakob disease. Transfusion 44 (2004) 1475-1478
11. McCullough J., Anderson D., Brookie D., et al. Consensus conference on vCJD screening of blood donors: report of the panel. Transfusion 44 (2004) 675-683
12. Gregori L., McCombie N., Palmer D., et al. Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet 364 (2004) 529-531
13. Wilson K., and Ricketts M. Transfusion transmission of vCJD: a crisis avoided?. Lancet 364 (2004) 477-479